153 related articles for article (PubMed ID: 30431618)
1. Prognostic and clinical value of Targeting protein for Xenopus kinesin-like protein 2 in patients with gastrointestinal tract cancers: A meta-analysis.
Liu W; Xu J; Zhang C
Medicine (Baltimore); 2018 Nov; 97(46):e13303. PubMed ID: 30431618
[TBL] [Abstract][Full Text] [Related]
2. TPX2 as a Novel Prognostic Indicator and Promising Therapeutic Target in Triple-negative Breast Cancer.
Jiang Y; Liu Y; Tan X; Yu S; Luo J
Clin Breast Cancer; 2019 Dec; 19(6):450-455. PubMed ID: 31494045
[TBL] [Abstract][Full Text] [Related]
3. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of Xenopus kinesin-like protein 2 as a prognostic marker in patients with digestive system cancers: a systematic review and meta-analysis.
Wang G; Wang Q; Li Z; Liu C; He X
Onco Targets Ther; 2018; 11():1229-1243. PubMed ID: 29551902
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of targeting protein for Xklp2 in solid tumors: A PRISMA-compliant systematic review and meta-analysis.
Wang S; Chen Y; Chai Y
Medicine (Baltimore); 2018 Oct; 97(43):e13018. PubMed ID: 30412141
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors.
Zhu M; Wang X; Zhang Q; Xie C; Wang T; Shen K; Zhang L; Zhou X
Aging (Albany NY); 2024 Feb; 16(3):2563-2590. PubMed ID: 38315450
[TBL] [Abstract][Full Text] [Related]
7. RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer.
Cáceres-Gorriti KY; Carmona E; Barrès V; Rahimi K; Létourneau IJ; Tonin PN; Provencher D; Mes-Masson AM
PLoS One; 2014; 9(3):e91000. PubMed ID: 24625450
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance and prognostic value of Xenopus kinesin-like protein 2 expressions in human tumors: A systematic review and meta-analysis.
Yang W; Wan H; Shan R; Wen W; Li J; Luo D; Wan RH
J Cell Physiol; 2019 Sep; 234(9):14991-14998. PubMed ID: 30779127
[TBL] [Abstract][Full Text] [Related]
9. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
Glaser ZA; Love HD; Guo S; Gellert L; Chang SS; Herrell SD; Barocas DA; Penson DF; Cookson MS; Clark PE
Urol Oncol; 2017 May; 35(5):286-293. PubMed ID: 28108243
[TBL] [Abstract][Full Text] [Related]
10. Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancer.
Liang B; Zheng W; Fang L; Wu L; Zhou F; Yin X; Yu X; Zou Z
Cancer Biol Ther; 2016 Aug; 17(8):824-32. PubMed ID: 27314162
[TBL] [Abstract][Full Text] [Related]
11. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
[TBL] [Abstract][Full Text] [Related]
12. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of TPX2 predicts poor clinical outcome and is associated with immune infiltration in hepatic cell cancer.
Zhu H; Liu J; Feng J; Zhang Q; Bian T; Li X; Sun H; Zhang J; Liu Y
Medicine (Baltimore); 2020 Dec; 99(49):e23554. PubMed ID: 33285774
[TBL] [Abstract][Full Text] [Related]
14. TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer.
Wei P; Zhang N; Xu Y; Li X; Shi D; Wang Y; Li D; Cai S
J Transl Med; 2013 Dec; 11():313. PubMed ID: 24341487
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of LncRNA PVT1 Predicts Advanced Clinicopathological Features and Serves as an Unfavorable Risk Factor for Survival of Patients with Gastrointestinal Cancers.
Liu F; Dong Q; Huang J
Cell Physiol Biochem; 2017; 43(3):1077-1089. PubMed ID: 28968599
[TBL] [Abstract][Full Text] [Related]
16. TPX2 level correlates with cholangiocarcinoma cell proliferation, apoptosis, and EMT.
Zou Z; Zheng B; Li J; Lv X; Zhang H; Yu F; Kong L; Li Y; Yu M; Fang L; Liang B
Biomed Pharmacother; 2018 Nov; 107():1286-1293. PubMed ID: 30257343
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies.
Shao T; Jiang X; Bao G; Li C; Guo C
Dis Markers; 2022; 2022():7571066. PubMed ID: 36304254
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of targeting protein for Xenopus kinesin-like protein 2 (TPX2) at threonine 72 in spindle assembly.
Shim SY; Perez de Castro I; Neumayer G; Wang J; Park SK; Sanada K; Nguyen MD
J Biol Chem; 2015 Apr; 290(14):9122-34. PubMed ID: 25688093
[TBL] [Abstract][Full Text] [Related]
20. Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer.
Chen M; Zhang H; Zhang G; Zhong A; Ma Q; Kai J; Tong Y; Xie S; Wang Y; Zheng H; Guo L; Lu R
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):74-82. PubMed ID: 30454896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
